Evaluation of fructosamine concentration as an index marker for glycaemic control in diabetic dogs.

Abstract

BACKGROUND: Although fructosamine is a commonly used surrogate marker to assess glycaemic control in diabetic dogs, its diagnostic accuracy has been questioned. The main objective of this study was to evaluate the reliability of fructosamine measurements to diagnose well and poorly controlled diabetes mellitus (DM), using continuous glucose monitoring as a gold standard. METHODS: Twenty-four dogs with treated DM and continuous glucose monitoring for mean (&#xb1;SD) 13.1 (&#xb1;1.7) days were retrospectively analysed. Two assessment strategies were applied to categorize glycaemic control, and fructosamine concentrations were determined shortly after sensor cessation using a colorimetric assay. RESULTS: Correlations of individual fructosamine concentrations with mean glucose as well as percentage of measurements&#xa0;>&#xa0;15&#xa0;mmol/L were not significant (p&#xa0;=&#xa0;0.372, p&#xa0;=&#xa0;0.129). Fructosamine did not differ between dogs with and without hypoglycaemic episodes (p&#xa0;=&#xa0;0.64). Receiver operating characteristic analysis for fructosamine to diagnose either good or poor glycaemic control revealed AUC values of 0.71 (p&#xa0;=&#xa0;0.025) indicating moderate accuracy, and 0.7 (p&#xa0;=&#xa0;0.135) indicating AUC is non-discriminatory, respectively. The respective positive likelihood ratios for the optimal cutoffs to identify good (<396&#xa0;&#x3bc;mol/L) and poor control (>449&#xa0;&#x3bc;mol/L) were three. CONCLUSIONS: Fructosamine measurement is an imperfect surrogate marker for classifying glycaemic control in diabetic dogs and can only complement serial glucose measurements.